Come up with a name for your new list and we'll add to it:
TheraVasc raised a round of funding on July 24, 2009. Investors include
Innovation Fund America.
TheraVasc is a privately-held biotechnology company with offices in Louisiana, focused on the development of vascular therapies with decreased risks through the repositioning of drugs with known safet…